SCHEMBL20157656

SCHEMBL20157656

COCCOc1ncc2[nH]c(=O)[nH]c2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYRO3 Q06418 2/20 0.49
▸ DYRK1B Q9Y463 2/20 0.49
▸ PDE3B Q13370 18/20 0.42
▸ PDE3A Q14432 18/20 0.42
▸ P2RY12 Q9H244 9/20 0.40
▸ AURKA O14965 1/20 0.38
▸ DAPK3 O43293 1/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ PRKD3 O94806 1/20 0.38
▸ MAP4K4 O95819 1/20 0.38
▸ PAK4 O96013 1/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ NTRK1 P04629 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ RET P07949 1/20 0.38
▸ MET P08581 1/20 0.38
▸ PDGFRB P09619 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ FGFR1 P11362 1/20 0.38
▸ PDGFRA P16234 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29475651 0.85 TYRO3 (0.49) TYRO3DYRK1BPDE3BPDE3AP2RY12
SCHEMBL30323763 0.83 TYRO3 (0.53) TYRO3DYRK1BPDE3BPDE3AP2RY12
SCHEMBL20157605 0.73 NUDT1 (0.39) PDE3BPDE3AP2RY12DYRK1A
SCHEMBL20157445 0.72 PDE3B (0.45) PDE3BPDE3AP2RY12PDE2A
SCHEMBL28671355 0.72 TYRO3 (0.56) TYRO3DYRK1BPDE3BPDE3AP2RY12
SCHEMBL29454533 0.72 TLR7 (0.49) —
SCHEMBL20157464 0.71 TSHR (0.36) FGFR1
SCHEMBL11904050 0.70 TYRO3 (0.61) TYRO3DYRK1BPDE3BPDE3AP2RY12
SCHEMBL6027523 0.69 ALDH1A1 (0.46) CDK7CDK9
SCHEMBL21514305 0.67 TRPV1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539963-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE Livo (Shanghai) Pharmaceutical Co., Ltd (CN) 2019-09-18 — — EP disclosed
WO-2018086593-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE 礼沃(上海)医药科技有限公司 2018-05-17 — — WO disclosed
Send feedback